PTGX Stock Earnings: Protagonist Therapeutics Beats EPS, Misses Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

PTGX stock results show that Protagonist Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

The post PTGX Stock Earnings: Protagonist Therapeutics Beats EPS, Misses Revenue for Q2 2024 appeared first on InvestorPlace.

More From InvestorPlace

• Legendary Investor Predicts: “Forget AI... THIS Technology Is the Future”